Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04171960 · ClinicalTrials.gov registry record
Clinical Evaluation of the i-STAT TBI Test
A clinical trial, sponsored by Abbott Point of Care.
- Completed
- Registry status
- 1,106
- Enrollment target
NCT04171960: Completed study, sponsored by Abbott Point of Care.
NCT04171960 is a clinical trial that has completed, run by Abbott Point of Care. The registered enrollment target is 1,106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04171960 has completed, sponsored by Abbott Point of Care.
- COMPLETED
- Registry status
- 1,106 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the i-STAT TBI test to assist determining the need for a computed tomography (CT) scan in patients with suspected mild traumatic brain injury (TBI). Patients will be asked to provide a blood sample.
Primary Outcome
Results of the i-STAT TBI Test (elevated/not elevated) relative to CT findings (+/-) for intra-cranial lesions for each subject.
Interventions
- DIAGNOSTIC_TEST Blood draw
- OTHER Outcome assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,106 participants |
| Start Date | 2020-07-31 |
| Est. Completion | 2023-11-29 |
What the finished NCT04171960 record still lists
NCT04171960 is an observational study that tracks outcomes without assigning an intervention. Its 1,106 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT04171960 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04171960 about?
NCT04171960 is a clinical study titled "Clinical Evaluation of the i-STAT TBI Test". The goal of this study is to evaluate the i-STAT TBI test to assist determining the need for a computed tomography (CT) scan in patients with suspected mild traumatic brain injury (TBI). Patients will be asked to provide a blood sample.
What is the current status of trial NCT04171960?
This trial is currently completed. The enrollment target is 1,106 participants. The study started on 2020-07-31. Estimated completion is 2023-11-29.
What interventions are being tested in trial NCT04171960?
The interventions under investigation include: Blood draw (DIAGNOSTIC_TEST), Outcome assessments (OTHER).
Who is sponsoring clinical trial NCT04171960?
This trial is sponsored by Abbott Point of Care, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI